Caxton Associates (New York)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $62.6M | Buy |
701,105
+1,105
| +0.2% | +$98.7K | 1.97% | 7 |
|
|
2024
Q3 | $58.7M | Buy |
+700,000
| New | +$58.7M | 2.2% | 5 |
|
|
2023
Q1 | – | Sell |
-50,000
| Closed | -$2.31M | – | 500 |
|
|
2022
Q4 | $2.31M | Hold |
50,000
| – | – | 0.15% | 27 |
|
|
2022
Q3 | $1.94M | Buy |
+50,000
| New | +$1.94M | 0.26% | 23 |
|
|
2020
Q4 | – | Sell |
-75,000
| Closed | -$2.87M | – | 136 |
|
|
2020
Q3 | $2.87M | Buy |
+75,000
| New | +$2.87M | 0.3% | 24 |
|
|
2019
Q2 | – | Sell |
-21,840
| Closed | -$838K | – | 392 |
|
|
2019
Q1 | $838K | Buy |
+21,840
| New | +$838K | 0.12% | 81 |
|
|
2018
Q4 | – | Sell |
-6,499
| Closed | -$250K | – | 285 |
|
|
2018
Q3 | $250K | Buy |
+6,499
| New | +$250K | 0.02% | 304 |
|
|
2018
Q1 | – | Sell |
-44,975
| Closed | -$1.12M | – | 289 |
|
|
2017
Q4 | $1.12M | Buy |
+44,975
| New | +$1.12M | 0.05% | 146 |
|
|
2017
Q2 | – | Sell |
-20,100
| Closed | -$500K | – | 416 |
|
|
2017
Q1 | $500K | Buy |
+20,100
| New | +$500K | ﹤0.01% | 193 |
|
|
2015
Q2 | – | Sell |
-225,000
| Closed | -$3.99M | – | 125 |
|
|
2015
Q1 | $3.99M | Buy |
+225,000
| New | +$3.99M | 0.17% | 69 |
|